Featured Research

from universities, journals, and other organizations

High-tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms

Date:
November 14, 2006
Source:
Wake Forest University Baptist Medical Center
Summary:
Magnetic resonance spectroscopy may provide a noninvasive way to monitor neuropsychiatric symptoms in patients with lupus, according to results from research in mice at Wake Forest University School of Medicine.

Magnetic resonance spectroscopy (MRS) may provide a noninvasive way to monitor neuropsychiatric symptoms in patients with lupus, according to results from research in mice at Wake Forest University School of Medicine.

Related Articles


"This study is the first to demonstrate that MRS is a feasible method to monitor neuropsychiatric symptoms in lupus," said Nilamadhab Mishra, M.D., the principal investigator, in a presentation at the American College of Rheumatology meeting in Washington.

MRS is closely related to MRI (magnetic resonance imaging), and uses strong magnetic fields and low energy radio waves to get biochemical information about the body. The test is done in an MRI machine to which a spectrometer has been attached to measure changes in metabolites, such as the levels of glutamate and glutamine.

"Because of its noninvasiveness and repeatable nature, MRS could be helpful in the drug discovery program for neuropsychiatric lupus," said Mishra, an assistant professor of rheumatology. He explained, "No definitive biomarker of neuropsychiatric lupus is available and this impedes both clinical diagnosis and drug discovery for treatment of this condition."

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in neuropsychiatric lupus, there are a wide variety of associated neurological and psychiatric syndromes and cognitive problems.

NIAMS, which is supporting Mishra's work, said that about 20 percent of lupus patients have neuropsychiatric symptoms and it is one of the major causes of death among people with lupus. Systemic lupus affects an estimated 1.5 million Americans, mostly women.

In his study, Mishra is using mice that have a defective gene and spontaneously develop lupus, including lymph node swelling and increased spleen size. He is comparing these animals with control animals that do not have lupus.

His results showed "a dramatic decrease" in the ratio of two biochemicals, glutamate and glutamine as measured by MRS in the mice with lupus compared with control mice as early as seven weeks of life, which directly paralleled behavioral tests. Other biochemical pairs also showed changes, but not as dramatically as glutamate/glutamine. At 11 and 15 weeks, there were significant further decreases in the glutamate/glutamine ratio.

Mishra and his colleagues tested cognitive performance using a water maze test, a standard test to assess spatial learning and memory in rodents. "The water maze test measures memory, learning and cognitive function. We correlated the changes in metabolites in different age groups to behavior changes," he said.

The mice in the lupus group had significantly poorer cognitive function at seven weeks, tracking the decline in the glutamate/glutamine ratio. Cognitive function "continued to deteriorate further with advancing age, whereas there was no change in control mice."

"This tells us that MRS can be useful for monitoring the disease instead of time-consuming behavioral studies," he said. The changes in the glutamate/glutamine ratio indicate that the neuropsychiatric lupus is getting progressively worse.

But precisely how the biochemical changes equate to neuropsychiatric symptoms in people will await future human studies, he said.

Co-authors included Todd Atwood, M.S., Anh Nghiem, B.S., Christy Carter, Ph.D., and Jian-Ming Zhu., Ph.D., assistant professor of radiation oncology.


Story Source:

The above story is based on materials provided by Wake Forest University Baptist Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Wake Forest University Baptist Medical Center. "High-tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms." ScienceDaily. ScienceDaily, 14 November 2006. <www.sciencedaily.com/releases/2006/11/061112094516.htm>.
Wake Forest University Baptist Medical Center. (2006, November 14). High-tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2006/11/061112094516.htm
Wake Forest University Baptist Medical Center. "High-tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms." ScienceDaily. www.sciencedaily.com/releases/2006/11/061112094516.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins